Works matching DE "JOHNSON %26 Johnson Innovative Medicine (Company)"
1
- ONS News, 2004, v. 19, n. 5, p. 13
- Article
2
- Formulary, 2007, v. 42, n. 11, p. 627
- Article
3
- Psychiatry (1550-5952), 2009, v. 6, n. 1, p. 12
- Article
5
- Urology Times, 2005, v. 33, n. 4, p. 39
- Article
6
- Urology Times, 2004, v. 32, n. 17, p. 39
- Article
8
- Expert Review of Clinical Pharmacology, 2012, v. 5, n. 1, p. 15
- Article
9
- Contemporary OB/GYN, 2006, v. 51, n. 1, p. 17
- Article
10
- Contemporary OB/GYN, 2002, v. 47, n. 11, p. 124
- Article
11
- Contemporary OB/GYN, 2001, v. 46, n. 7, p. 133
- Article
12
- JAMA: Journal of the American Medical Association, 2002, v. 287, n. 5, p. 578, doi. 10.1001/jama.287.5.578-JFD20002-2-1
- Article
13
- Clinical Infectious Diseases, 2007, v. 45, p. S196, doi. 10.1086/519502
- Article
14
- TCE: The Chemical Engineer, 2017, n. 909, p. 20
- Article
15
- Journal of Psychosocial Nursing & Mental Health Services, 2005, v. 43, n. 6, p. 16
- Article
16
- Journal of Generic Medicines, 2011, v. 8, n. 1, p. 57, doi. 10.1057/jgm.2010.34
- Article
17
- Journal of Law, Medicine & Ethics, 1996, v. 24, n. 1, p. 73, doi. 10.1017/s1073110500004605
- Article
18
- Perspectives in Public Health, 2015, v. 135, n. 2, p. 59, doi. 10.1177/1757913915572755
- Article
19
- Psychiatric Times, 2004, v. 21, n. 2, p. 78
- Article
20
- Strategic Finance, 2014, v. 95, n. 8, p. 13
- Article
21
- Brown University Psychopharmacology Update, 2004, v. 15, n. 2, p. 8
- Article
22
- Journal of Pain & Palliative Care Pharmacotherapy, 2006, v. 20, n. 4, p. 128
- Article
23
- Formulary, 1999, v. 34, n. 11, p. 892
- Article
24
- Applied Clinical Trials, 2017, v. 26, n. 2, p. 21
- Article
25
- Applied Clinical Trials, 2013, v. 22, n. 1, p. 8
- Article
26
- Applied Clinical Trials, 2005, v. 14, n. 10, p. 20
- Article
27
- Applied Clinical Trials, 2001, v. 10, n. 11, p. 14
- Article
28
- Nature Biotechnology, 2014, v. 32, n. 7, p. 607, doi. 10.1038/nbt0714-607b
- Article
29
- Nature Biotechnology, 2014, v. 32, n. 1, p. 3, doi. 10.1038/nbt0114-3
- Article
30
- Nature Biotechnology, 2013, v. 31, n. 6, p. 469, doi. 10.1038/nbt0613-469
- Article
31
- Journal of Investigative Dermatology, 1989, v. 93, n. 3, p. 313, doi. 10.1111/1523-1747.ep12280218
- Article
32
- Journal of Clinical & Aesthetic Dermatology, 2018, v. 11, n. 10, p. 44
- Article
33
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, p. 10, doi. 10.1111/ajco.12712
- Article
35
- 2021
- Karron, Ruth A.;
- Key, Nigel S.;
- Sharfstein, Joshua M.
- Editorial
36
- American Journal of Law & Medicine, 1986, v. 12, n. 2, p. 309
- Article
38
- Nature Biotechnology, 2011, v. 29, n. 4, p. 301, doi. 10.1038/nbt0411-301
- Article
39
- Dermatology Nursing, 2003, v. 15, n. 4, p. 384
- Article
40
- Journal of Health Care Compliance, 2011, v. 13, n. 5, p. 15
- Article